We have discovered that progranulin plays a critical role in bladder cancer by promoting urothelial cancer cell motility [9], and demonstrated that progranulin contributes as an autocrine growth factor to the transforming phenotype by regulating invasion and anchorage-independent growth [10, 11]. Here, GRN is linked to urinary bladder cancer.